Skip to main content

Tuning Macrophage Phenotype to Mitigate Skeletal Muscle Fibrosis.

Publication ,  Journal Article
Stepien, DM; Hwang, C; Marini, S; Pagani, CA; Sorkin, M; Visser, ND; Huber, AK; Edwards, NJ; Loder, SJ; Vasquez, K; Aguilar, CA; Kumar, R ...
Published in: J Immunol
April 15, 2020

Myeloid cells are critical to the development of fibrosis following muscle injury; however, the mechanism of their role in fibrosis formation remains unclear. In this study, we demonstrate that myeloid cell-derived TGF-β1 signaling is increased in a profibrotic ischemia reperfusion and cardiotoxin muscle injury model. We found that myeloid-specific deletion of Tgfb1 abrogates the fibrotic response in this injury model and reduces fibro/adipogenic progenitor cell proliferation while simultaneously enhancing muscle regeneration, which is abrogated by adaptive transfer of normal macrophages. Similarly, a murine TGFBRII-Fc ligand trap administered after injury significantly reduced muscle fibrosis and improved muscle regeneration. This study ultimately demonstrates that infiltrating myeloid cell TGF-β1 is responsible for the development of traumatic muscle fibrosis, and its blockade offers a promising therapeutic target for preventing muscle fibrosis after ischemic injury.

Duke Scholars

Published In

J Immunol

DOI

EISSN

1550-6606

Publication Date

April 15, 2020

Volume

204

Issue

8

Start / End Page

2203 / 2215

Location

England

Related Subject Headings

  • Transforming Growth Factor beta1
  • Reperfusion Injury
  • Phenotype
  • Myeloid Cells
  • Muscle, Skeletal
  • Mice, Transgenic
  • Mice, Inbred C57BL
  • Mice
  • Macrophages
  • Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stepien, D. M., Hwang, C., Marini, S., Pagani, C. A., Sorkin, M., Visser, N. D., … Levi, B. (2020). Tuning Macrophage Phenotype to Mitigate Skeletal Muscle Fibrosis. J Immunol, 204(8), 2203–2215. https://doi.org/10.4049/jimmunol.1900814
Stepien, David M., Charles Hwang, Simone Marini, Chase A. Pagani, Michael Sorkin, Noelle D. Visser, Amanda K. Huber, et al. “Tuning Macrophage Phenotype to Mitigate Skeletal Muscle Fibrosis.J Immunol 204, no. 8 (April 15, 2020): 2203–15. https://doi.org/10.4049/jimmunol.1900814.
Stepien DM, Hwang C, Marini S, Pagani CA, Sorkin M, Visser ND, et al. Tuning Macrophage Phenotype to Mitigate Skeletal Muscle Fibrosis. J Immunol. 2020 Apr 15;204(8):2203–15.
Stepien, David M., et al. “Tuning Macrophage Phenotype to Mitigate Skeletal Muscle Fibrosis.J Immunol, vol. 204, no. 8, Apr. 2020, pp. 2203–15. Pubmed, doi:10.4049/jimmunol.1900814.
Stepien DM, Hwang C, Marini S, Pagani CA, Sorkin M, Visser ND, Huber AK, Edwards NJ, Loder SJ, Vasquez K, Aguilar CA, Kumar R, Mascharak S, Longaker MT, Li J, Levi B. Tuning Macrophage Phenotype to Mitigate Skeletal Muscle Fibrosis. J Immunol. 2020 Apr 15;204(8):2203–2215.

Published In

J Immunol

DOI

EISSN

1550-6606

Publication Date

April 15, 2020

Volume

204

Issue

8

Start / End Page

2203 / 2215

Location

England

Related Subject Headings

  • Transforming Growth Factor beta1
  • Reperfusion Injury
  • Phenotype
  • Myeloid Cells
  • Muscle, Skeletal
  • Mice, Transgenic
  • Mice, Inbred C57BL
  • Mice
  • Macrophages
  • Immunology